OnKure Expands Executive Team with the Addition of Chief Scientific Officer and Chief Development Officer

He joined Arvinas as the Chief Scientific Officer, helping the new company focus on a novel technology, validating and further advancing this technology, and building a growing preclinical pipeline, enabling Arvinas to go public.